VRC01 Antibody Prolonged Time to HIV Viral Rebound After Treatment Interruption. Study administered broadly neutralizing antibody infusions to virally suppressed volunteers who initiated ART during acute HIV infection.
Late HIV Vaccine Boost Elicits Higher Immune Response in Volunteers
from the RV144 Thai Trial. New study evaluates effects of boost given to volunteers 6-8 years after their initial vaccination in the RV144 HIV vaccine trial.